Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NETWORK × Adenocarcinoma × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 60 INDUSTRY 20 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 16 Neoplasms 10 Multiple Myeloma 10 Prostatic Neoplasms 9 Melanoma 8 Carcinoma, Non-Small-Cell Lung 8 Pancreatic Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma 6 Colorectal Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Non-Hodgkin 5 Leukemia, Myeloid, Acute 5 Hodgkin Disease 5 Sarcoma 4 Ovarian Neoplasms 4 Teratoma 3 Smoldering Multiple Myeloma 3 Small Cell Lung Carcinoma 3 Osteosarcoma 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Leukemia 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 HIV Infections 3 Esophageal Neoplasms 3 Central Nervous System Neoplasms 3 Carcinoma, Hepatocellular 3 Carcinoma, Embryonal 3

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1 abiraterone 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06592924 2026-01-14

TRIPLE-SWITCH

Canadian Cancer Trials Group

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡